Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized Placebo-Controlled Trial of Sub-Dissociative Ketamine for Treatment of Acute Migraine-Type Headache in the Emergency Department

To see complete record on, please visit this link

Id: NCT02697071

Organisation Name: Carilion Clinic

Overal Status: Completed

Start Date: February 2016

Last Update: March 26, 2021

Lead Sponsor: Carilion Clinic

Brief Summary: This research study will be a prospective, randomized, double-blind, placebo-controlled trial. Because ketamine has yet to be directly studied as treatment for acute migraine headache in the emergency department, the research team is initially interested if ketamine can reduce pain scores in headache patients and reduce the incidence of recurrence while exhibiting an adequate safety profile. By using a placebo-controlled study design, the research team can adequately investigate the effectiveness of the medication in a subgroup previously not well studied.

  • Headache

Total execution time in seconds: 0.23971700668335